Medical Communications

Showing 15 posts of 6418 posts found.

lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015 Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …
michael_koslowski_picture

Mission Therapeutics appoints new chief medical officer

September 9, 2015 Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …

Biocair International Ltd achieves AEO approval

September 8, 2015 Medical Communications Biocair

We are pleased to announce that as of 8th September 2015 Biocair International Ltd is an Authorised Economic Operator (AEO). …
avastin

New treatment option for ovarian cancer patients in Scotland

September 8, 2015 Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …
mehwish_abdeali

Wave appoints Mehwish Abdeali as senior programme executive

September 8, 2015 Medical Communications Mehwish Abdeali, wave

Mehwish Abdeali has been appointed as senior programme executive at Wave, a specialist medical education company. Mehwish joins Wave from …
NHS sign

Companies braced for new round of cancer cuts

September 4, 2015 Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, cuts

Several treatments that extend the lives of people with cancer are expected to be removed from the Cancer Drugs Fund …
laptop stethoscope

Health ministers vow NHS tech revolution

September 3, 2015 Medical Communications Jeremy Hunt, NHS, data protection, digital technology, george freeman

UK health ministers have challenged the NHS to fully utilise technology, to empower patients to manage their own healthcare needs.Their …
CEP report

Pharma ‘spends €40m to sway EU politicians’

September 2, 2015 Medical Communications EU, European Commission, TTIP, drug policy, lobbying, transparency

The pharma industry has excessive power over EU decision-makers and spends €40 million a year to influence EU drug policy, …
google logo

Sanofi joins Google in diabetes tech push

September 1, 2015 Medical Communications Andy Conrad, Google life sciences, Sanofi, Type 1 diabetes, diabetes, google, type 2 diabetes

Google is continuing its work in diabetes, by teaming up with pharma giants Sanofi to create new digital technologies and …
scales

Standardising the pharma benefit-risk assessment process

September 1, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, benefit-risk analysis, pharmacoepidemiology, pharmacovigilance

Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view …
mytrus_cartoon

NHS approves electronic consent technology in clinical trials

August 28, 2015 Medical Communications, Research and Development Mytrus, NHS, clinical trials, digital health technology, electronic informed consent

Clinical technology and services company Mytrus has announced that its software platform for electronic informed consent has received approval for …

FDA approves Amgen’s cholesterol lowering drug

August 28, 2015 Medical Communications, Research and Development Amgen, FDA, Repatha, evolocumab

The FDA has endorsed Amgen’s cholesterol-lowering medication, Repatha, for the use in patients with high cholesterol. It follows Amgen’s successful …
Sanofi's go meals app

Moves in pharma app market, but user longevity an issue

August 28, 2015 Medical Communications Communication, apps, digital, medcomms, medical communications, mobile

Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same …
ESC congress sign

NHS looks to ESC for next-gen heart drug data

August 28, 2015 Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …
The Gateway to Local Adoption Series

Latest content